Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Finasteride was successfully synthesized from Pregnadienolone acetate.

New compounds with carborane showed anti-androgen effects similar to flutamide.

A new method to make Finasteride is more cost-effective and yields 16%.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

The new method makes finasteride cheaper and easier to produce.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

New compounds show promise as nonsteroidal treatments for hair loss.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.